Dual-energy CT (clinical applications)
Last revised by Dr Yuranga Weerakkody ◉ on 04 Mar 2021
Citation, DOI & article data
Citation:
Murphy, A., Weerakkody, Y. Dual-energy CT (clinical applications). Reference article, Radiopaedia.org. (accessed on 27 Jun 2022) https://doi.org/10.53347/rID-46831
rID:
46831
Article created:
19 Jul 2016 by Andrew Murphy ◉
Revisions:
35 times by 5 users - see full revision history
Systems:
-
Section:
Tags:
-
Synonyms:
- spectral imaging
- DECT
Dual-energy CT or multispectral CT is becoming increasingly more common in clinical practice due to the rapid rise in computer technology and expanding literature exhibiting vast advantages over conventional single energy CT.
Clinical applications
The clinical practice, adaptation and techniques of dual-energy CT is broken into individual articles:
- virtual non-contrast imaging
-
vascular
- automated bone removal in CT angiography 2
- decrease metal device artifact 7
- detection of endoleaks 7
- blood pool imaging 2
- detection of pulmonary embolism
- detection of myocardial ischemia
-
urinary system
- characterization of renal stones 2
- characterization of renal cysts and masses 2-4
-
neuroimaging
- differentiation of hemorrhage from iodinated contrast
- quantification of iodine leak in traumatic hemorrhagic contusions
- bone removal
- optimizing imaging
-
female breast
- identification of silicone leaks from breast implants 2
- improved tumor conspicuity of breast cancers relative to conventional CT, with the potential determination of prognostic biomarkers such as ER and PR status 6
-
musculoskeletal
- detection of bone marrow edema
- detection and quantification of urate crystals in gout
- reduction of metal artifact 7
-
abdominal imaging
- pancreatic diseases 5
- thoracic imaging
- detection of pulmonary thromboembolism; structural as well as functional information is obtained through iodine maps of pulmonary perfusion 7
- assessment of a solitary pulmonary nodule to determine malignancy status 7,8
References
- 1. Fornaro J, Leschka S, Hibbeln D, Butler A, Anderson N, Pache G, Scheffel H, Wildermuth S, Alkadhi H, Stolzmann P. Dual- and multi-energy CT: approach to functional imaging. (2011) Insights into imaging. 2 (2): 149-159. doi:10.1007/s13244-010-0057-0 - Pubmed
- 2. McCollough CH, Leng S, Yu L, Fletcher JG. Dual- and Multi-Energy CT: Principles, Technical Approaches, and Clinical Applications. (2015) Radiology. 276 (3): 637-53. doi:10.1148/radiol.2015142631 - Pubmed
- 3. Mileto A, Nelson RC, Paulson EK, Marin D. Dual-Energy MDCT for Imaging the Renal Mass. (2015) AJR. American journal of roentgenology. 204 (6): W640-7. doi:10.2214/AJR.14.14094 - Pubmed
- 4. Kessner R, Große Hokamp N, Ciancibello L, Ramaiya N, Herrmann KA. Renal cystic lesions characterization using spectral detector CT (SDCT): Added value of spectral results. (2019) The British journal of radiology. 92 (1100): 20180915. doi:10.1259/bjr.20180915 - Pubmed
- 5. George E, Wortman JR, Fulwadhva UP, Uyeda JW, Sodickson AD. Dual energy CT applications in pancreatic pathologies. (2017) The British journal of radiology. 90 (1080): 20170411. doi:10.1259/bjr.20170411 - Pubmed
- 6. Moon J Il, Choi BH, Baek HJ, Ryu KH, Park SE, Ha JY, et al. Comprehensive analyses with radiological and biological markers of breast cancer on contrast-enhanced chest CT: a single center experience using dual-layer spectral detector CT. Eur Radiol. 2020 May 1;30(5):2782–90.
- 7. 1. Cicero G, Ascenti G, Albrecht MH, Blandino A, Cavallaro M, D’Angelo T, et al. Extra-abdominal dual-energy CT applications: a comprehensive overview. Radiol Medica. 2020 Apr 1;125(4):384–97.
- 8. Wu L, Cao G, Zhao L, Tang K, Lin J, Miao S, et al. Spectral CT Analysis of Solitary Pulmonary Nodules for Differentiating Malignancy from Benignancy: The Value of Iodine Concentration Spatial Distribution Difference. Biomed Res Int. 2018;2018:4830659.
Related articles: Imaging technology
- imaging technology
- imaging physics
- imaging in practice
-
x-rays
- x-ray physics
- x-ray in practice
- x-ray production
- x-ray tube
- filters
- automatic exposure control (AEC)
- beam collimators
- grids
- air gap technique
- cassette
- intensifying screen
- x-ray film
- image intensifier
- digital radiography
- digital image
- mammography
- x-ray artifacts
- radiation units
- radiation safety
- radiation detectors
- fluoroscopy
-
computed tomography (CT)
- CT physics
- CT in practice
- CT technology
- CT image reconstruction
- CT image quality
- CT dose
-
CT contrast media
-
iodinated contrast media
- agents
- water soluble
- water insoluble
- vicarious contrast material excretion
- iodinated contrast media adverse reactions
- agents
- non-iodinated contrast media
-
iodinated contrast media
-
CT artifacts
- patient-based artifacts
- physics-based artifacts
- hardware-based artifacts
- ring artifact
- tube arcing
- out of field artifact
- air bubble artifact
- helical and multichannel artifacts
- CT safety
- history of CT
-
MRI
- MRI physics
- MRI in practice
- MRI hardware
- signal processing
-
MRI pulse sequences (basics | abbreviations | parameters)
- T1 weighted image
- T2 weighted image
- proton density weighted image
- chemical exchange saturation transfer
- CSF flow studies
- diffusion weighted imaging (DWI)
- echo-planar pulse sequences
- fat-suppressed imaging sequences
- gradient echo sequences
- inversion recovery sequences
- metal artifact reduction sequence (MARS)
-
perfusion-weighted imaging
- techniques
- derived values
- saturation recovery sequences
- spin echo sequences
- spiral pulse sequences
- susceptibility-weighted imaging (SWI)
- T1 rho
- MR angiography (and venography)
-
MR spectroscopy (MRS)
- 2-hydroxyglutarate peak: resonates at 2.25 ppm
- alanine peak: resonates at 1.48 ppm
- choline peak: resonates at 3.2 ppm
- citrate peak: resonates at 2.6 ppm
- creatine peak: resonates at 3.0 ppm
- functional MRI (fMRI)
- gamma-aminobutyric acid (GABA) peak: resonates at 2.2-2.4 ppm
- glutamine-glutamate peak: resonates at 2.2-2.4 ppm
- Hunter's angle
- lactate peak: resonates at 1.3 ppm
- lipids peak: resonates at 1.3 ppm
- myoinositol peak: resonates at 3.5 ppm
- MR fingerprinting
- N-acetylaspartate (NAA) peak: resonates at 2.0 ppm
- propylene glycol peak: resonates at 1.13 ppm
-
MRI artifacts
- MRI hardware and room shielding
- MRI software
- patient and physiologic motion
- tissue heterogeneity and foreign bodies
- Fourier transform and Nyquist sampling theorem
- MRI contrast agents
- MRI safety
-
ultrasound
- ultrasound physics
-
transducers
- linear array
- convex array
- phased array
- frame averaging (frame persistence)
- ultrasound image resolution
- imaging modes and display
- pulse-echo imaging
- real-time imaging
-
Doppler imaging
- Doppler effect
- color Doppler
- power Doppler
- B flow
- color box
- Doppler angle
- pulse repetition frequency and scale
- wall filter
- color write priority
- packet size (dwell time)
- peak systolic velocity
- end-diastolic velocity
- resistive index
- pulsatility index
- Reynolds number
- panoramic imaging
- compound imaging
- harmonic imaging
- elastography
- scanning modes
- 2D ultrasound
- 3D ultrasound
- 4D ultrasound
- M-mode
-
ultrasound artifacts
- acoustic shadowing
- acoustic enhancement
- beam width artifact
- reverberation artifact
- ring down artifact
- mirror image artifact
- side lobe artifact
- speckle artifact
- speed displacement artifact
- refraction artifact
- multipath artifact
- anisotropy
- electrical interference artifact
- hardware-related artifacts
- Doppler artifacts
- aliasing
- tissue vibration
- spectral broadening
- blooming
- motion (flash) artifact
- twinkling artifact
- acoustic streaming
- biological effects of ultrasound
- history of ultrasound
-
nuclear medicine
- nuclear medicine physics
- detectors
- tissue to background ratio
-
radiopharmaceuticals
- fundamentals of radiopharmaceuticals
- radiopharmaceutical labeling
- radiopharmaceutical production
- nuclear reactor produced radionuclides
- cyclotron produced radionuclides
- radiation detection
- dosimetry
- specific agents
- carbon-11
- chromium-51
- fluorine agents
- gallium agents
- Ga-67 citrate
- Ga-68
- iodine agents
-
I-123
- I-123 iodide
- I-123 ioflupane (DaTSCAN)
- I-123 ortho-iodohippurate
- I-131
-
MIBG scans
- I-123 MIBG
- I-131 MIBG
-
I-123
- indium agents
- In-111 Octreoscan
- In-111 OncoScint
- In-111 Prostascint
- In-111 oxine labeled WBC
- krypton-81m
- nitrogen-13
- oxygen-15
- phosphorus-32
- selenium-75
-
technetium agents
- Tc-99m DMSA
- Tc-99m DTPA
- Tc-99m DTPA aerosol
- Tc-99m HMPAO
- Tc-99m HMPAO labeled WBC
- Tc-99m MAA
- Tc-99m MAG3
- Tc-99m MDP
- Tc-99m mercaptoacetyltriglycine
- Tc-99m pertechnetate
- Tc-99m labeled RBC
- Tc-99m sestamibi
- Tc-99m sulfur colloid
- Tc-99m sulfur colloid (oral)
- thallium-201 chloride
- xenon agents
- in vivo therapeutic agents
- pharmaceuticals used in nuclear medicine
-
emerging methods in medical imaging
- radiography
- phase-contrast imaging
- CT
- deep-learning reconstruction
- photon counting CT
- virtual non-contrast imaging
- ultrasound
- magnetomotive ultrasound (MMUS)
- superb microvascular imaging
- ultrafast Doppler imaging
- ultrasound localization microscopy
- MRI
- nuclear medicine
- total body PET system
- immuno-PET
- miscellaneous
- radiography